Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 Jun;22(2):149-152.
doi: 10.1111/jns.12204.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

Ingemar S J Merkies  1 , John-Philip Lawo  2 , Jonathan M Edelman  3 , Jan L De Bleecker  4 , Claudia Sommer  5 , Wim Robberecht  6 , Mika Saarela  7 , Jerzy Kamienowski  8 , Zbigniew Stelmasiak  9 , Orell Mielke  2 , Björn Tackenberg  10 , Jean-Marc Léger  11 ; PRIMA trial investigators
Collaborators, Affiliations
Clinical Trial

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

Ingemar S J Merkies et al. J Peripher Nerv Syst. 2017 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Error bars represent 95% confidence intervals. The responder rates for the PRIMA study (non‐MCID) were reported previously (Merkies et al., 2010 ).
See this image and copyright information in PMC

References

    1. Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, van der Pol WL, Notermans NC, Nobile‐Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS (2014). Changing outcome in inflammatory neuropathies: Rasch‐comparative responsiveness. Neurology 83:2124–2132. - PubMed
    1. Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, van der Pol WL, Notermans NC, Nobile‐Orazio E, Lewis RA, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, van den Berg LH, van Doorn PA, Cornblath DR, Faber CG, Merkies IS (2015). Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses. J Peripher Nerv Syst 20:277–288. - PubMed
    1. Heesch KC, Masse LC, Dunn AL (2006). Using Rasch modeling to re‐evaluate three scales related to physical activity: enjoyment, perceived benefits and perceived barriers. Health Educ Res 21(Suppl 1):i58–i72. - PubMed
    1. Hobart J, Cano S (2009). Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13(iii, ix‐x):1–177. - PubMed
    1. Hughes R, Bensa S, Willison H, Van den BP, Comi G, Illa I, Nobile‐Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A (2001). Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195–201. - PubMed

MeSH terms

Substances

Associated data